QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 会议论文 JOURNAL OF NUCLEAR MEDICINE, 2019-05-01 作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong 收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03 Safety and response to(177)Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文 2019, 卷号: 60 作者:  Zang, Jie;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang;  Fan, Xinrong 收藏  |  浏览/下载：35/0  |  提交时间：2020/01/03 First-in-human study of Lu-177-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer 期刊论文 2019, 卷号: 46, 期号: 1, 页码: 148-158 作者:  Zang, Jie;  Fan, Xinrong;  Wang, Hao;  Liu, Qingxing;  Wang, Jingnan 收藏  |  浏览/下载：27/0  |  提交时间：2020/01/03 Radioligand therapy (RLT)  Lu-177  Evans blue  Prostate-specific membrane antigen (PSMA)  Metastatic castration-resistant prostate cancer (mCRPC)   Pretherapeutic Ga-68-PSMA-617 PET May Indicate the Dosimetry of Lu-177-PSMA-617 and Lu-177-EB-PSMA-617 in Main Organs and Tumor Lesions 期刊论文 2019, 卷号: 44, 期号: 6, 页码: 431-438 作者:  Wang, Jingnan;  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Li, Fang 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 Ga-68  Lu-177  prostate-specific membrane antigen (PSMA)  metastatic castration-resistant prostate cancer (mCRPC)  dosimetry   A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China 期刊论文 2019, 卷号: 15, 期号: 3, 页码: 144-150 作者:  He, Dalin;  Sun, Zhongquan;  Guo, Jianming;  Zhang, Zhigen;  Shan, Yuxi 收藏  |  浏览/下载：23/0  |  提交时间：2020/01/03 castration-resistant prostate cancer  docetaxel  observational   Safety and dosimetry of Lu-177-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer 期刊论文 2018, 卷号: 59 作者:  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Safety and dosimetry of Lu-177-EB-PSMA617 in patients with metastatic castration-resistant prostate cancer 会议论文 JOURNAL OF NUCLEAR MEDICINE, 2018-05-01 作者:  Zang, Jie;  Wang, Hao;  Liu, Qingxing;  Jacobson, Orit;  Niu, Gang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia 期刊论文 2017, 卷号: 4, 期号: 2, 页码: 75-85 作者:  Ye Dingwei;  Huang Yiran;  Zhou Fangjian;  Xie Keji;  Matveev Vsevolod 收藏  |  浏览/下载：12/0  |  提交时间：2020/01/04 Abiraterone  Chemotherapy-naïve  Metastatic castration-resistant prostate cancer  Prednisone  Prostate specific antigen   Abiraterone acetate for metastatic castration-resistant prostate cancer after docetaxel failure: A randomized, double-blind, placebo-controlled phase 3 bridging study 期刊论文 2016, 卷号: 23, 期号: 5, 页码: 404-411 作者:  Sun, Yinghao;  Zou, Qing;  Sun, Zhongquan;  Li, Changling;  Du, Chuanjun 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 abiraterone acetate  Asian population  castration-resistant prostate cancer  docetaxel  phase 3   Efficacy and safety of abiraterone acetate in asymptomatic or mildly symptomatic chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a phase III, double-blind, randomized, placebo-controlled study conducted in China, 会议论文 BJU INTERNATIONAL, 2015-08-01 作者:  Sun, Yinghao;  Ye, Dingwei;  Huang, Yiran;  Zhou, Fangjian;  Xie, Keji 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04